Biotechnology & Inventorship – What You Need To Know

3 Part Series
General CLE Credit Available

Enroll here | Greenberg Traurig Biographies

Inventorship is the threshold determination for patent rights.  As a result, individuals, research institutions, biotechnology start-ups, venture capitalists, and biopharma collaborators may face significant commercial implications from this determination, potentially with surprising (or even problematic) results.

In this three-part virtual series, BCLT & Greenberg Traurig discuss the law of biotechnology patent inventorship in patent prosecution, trade secret and patent litigation, and commercial transactions. The aim of this virtual speaker series is to educate biotechnology stake holders (scientists, entrepreneurs, funders, and their attorneys) on best practices for determining inventorship and addressing disputes, so that they may conduct their business affairs with greater certainty.

For anyone with a stake in a biotechnology invention, this series will help you optimize your rights and reduce your risks.  Don’t miss it!

Schedule

Part 1: Inventorship Determinations: Disputes and Best Practices

Tuesday, September 19, 2023
11:00 A.M – 12:15 P.M. (Pacific)

In part one, Inventorship Determinations: Disputes and Best Practices, join BCLT Life Sciences Director Allison Schmitt in conversation with Brent Sokol, an experienced biotech litigator, and Micheal Hebert, a leading life science patent prosecutor. We discuss the legal standard for inventorship, provide case examples, and share best practices for determining inventorship and handling disputes during prosecution.

Part 2: Trade Secrets and Inventorship: Disputes and Best Practices

Tuesday, September 26, 2023
11:00 A.M – 12:15 P.M. (Pacific)

In part two, Trade Secrets and Inventorship: Disputes and Best Practices, join BCLT Life Sciences Director Allison Schmitt in conversation with Brent Sokol, an experienced biotech litigator, and Greg Bombard, a widely-recognized trade secret trial lawyer. We provide an overview of trade secret law. We recommend best practices for trade secret protection, and explore inventorship issues as they arise in the context of trade secret disputes.

Part 3: Transactions and Inventorship: Best Practices for Diligence and Covenants

Tuesday, October 3, 2023
11:00 A.M – 12:15 P.M. (Pacific)

In part three, Transactions and Inventorship: Best Practices for Diligence and Covenants, join BCLT Life Sciences Director Allison Schmitt in conversation with Brent Sokol, an experienced biotech litigator, and Prashant Girinath, a top life sciences patent strategist. We examine the law of inventorship, recommend best practices for transaction readiness and diligence, and provide case examples in which an inventorship dispute impacted a commercial transaction.

About B-CLE